The Effect of Transitional Care on 30-Day Outcomes in Patients Hospitalised With Acute Heart Failure.


Journal

Heart, lung & circulation
ISSN: 1444-2892
Titre abrégé: Heart Lung Circ
Pays: Australia
ID NLM: 100963739

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 02 08 2019
revised: 01 01 2020
accepted: 01 03 2020
pubmed: 4 5 2020
medline: 14 4 2021
entrez: 4 5 2020
Statut: ppublish

Résumé

Patients admitted to hospital with acute heart failure (AHF) are at increased risk of readmission and mortality post-discharge. The aim of the study was to examine health service utilisation within 30 days post-discharge from an AHF hospitalisation. This was a prospective, observational, non-randomised study of consecutive patients hospitalised with acute HF to one of 16 Victorian hospitals over a 30-day period each year and followed up for 30 days post-discharge. The project was conducted annually over three consecutive years from 2015 to 2017. Of the 1,197 patients, 56.3% were male with an average age of 77±13.23 years. Over half of the patients (711, 62.5%) were referred to an outpatient clinic and a third (391, 34.4%) to a HF disease management program. In-hospital mortality was 5.1% with 30 day-mortality of 9% and readmission rate of 24.4%. Patients who experienced a subsequent readmission less than 10 days post-discharge and between 11 and 20 days post-discharge had a five- to six-fold increase in risk of mortality (adjusted OR 5.02, 95% CI 2.11-11.97; OR 6.45, 95% CI 2.69-15.42; respectively) compared to patients who were not readmitted to hospital. An outpatient appointment within 30 days post-discharge significantly reduced the risk of 30-day mortality by 81% (95% CI 0.09-0.43). Patients admitted to hospital with AHF who experience a subsequent readmission within 20 days post-discharge are at increased risk of dying. However, early follow-up post-discharge may reduce this risk. Early post-discharge follow-up is vital to address this vulnerable period after a HF admission.

Sections du résumé

BACKGROUND BACKGROUND
Patients admitted to hospital with acute heart failure (AHF) are at increased risk of readmission and mortality post-discharge. The aim of the study was to examine health service utilisation within 30 days post-discharge from an AHF hospitalisation.
METHODS METHODS
This was a prospective, observational, non-randomised study of consecutive patients hospitalised with acute HF to one of 16 Victorian hospitals over a 30-day period each year and followed up for 30 days post-discharge. The project was conducted annually over three consecutive years from 2015 to 2017.
RESULTS RESULTS
Of the 1,197 patients, 56.3% were male with an average age of 77±13.23 years. Over half of the patients (711, 62.5%) were referred to an outpatient clinic and a third (391, 34.4%) to a HF disease management program. In-hospital mortality was 5.1% with 30 day-mortality of 9% and readmission rate of 24.4%. Patients who experienced a subsequent readmission less than 10 days post-discharge and between 11 and 20 days post-discharge had a five- to six-fold increase in risk of mortality (adjusted OR 5.02, 95% CI 2.11-11.97; OR 6.45, 95% CI 2.69-15.42; respectively) compared to patients who were not readmitted to hospital. An outpatient appointment within 30 days post-discharge significantly reduced the risk of 30-day mortality by 81% (95% CI 0.09-0.43).
CONCLUSION CONCLUSIONS
Patients admitted to hospital with AHF who experience a subsequent readmission within 20 days post-discharge are at increased risk of dying. However, early follow-up post-discharge may reduce this risk. Early post-discharge follow-up is vital to address this vulnerable period after a HF admission.

Identifiants

pubmed: 32359870
pii: S1443-9506(20)30100-1
doi: 10.1016/j.hlc.2020.03.004
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1347-1355

Informations de copyright

Copyright © 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Auteurs

Andrea Driscoll (A)

School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia; School of Nursing and Midwifery, Deakin University, Geelong, Vic, Australia; Department of Cardiology, Austin Health, Melbourne, Vic, Australia. Electronic address: andrea.driscoll@deakin.edu.au.

Diem Dinh (D)

School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia.

David Prior (D)

Department of Cardiology, St Vincents Hospital, Melbourne, Vic, Australia; School of Medicine, University of Melbourne, Melbourne, Vic, Australia.

David Kaye (D)

Heart Failure Research Group, Baker Heart and Diabetes Institute, Melbourne, Vic, Australia; Department of Cardiology, Alfred Health, Melbourne, Vic, Australia.

David Hare (D)

Department of Cardiology, Austin Health, Melbourne, Vic, Australia; School of Medicine, University of Melbourne, Melbourne, Vic, Australia.

Christopher Neil (C)

Department of Cardiology, Western Health, Melbourne, Vic, Australia; School of Medicine, University of Melbourne, Melbourne, Vic, Australia.

Siobhan Lockwood (S)

Department of Cardiology, Monash Health, Melbourne, Vic, Australia.

Angela Brennan (A)

School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia.

Jeff Lefkovits (J)

School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia.

Harriet Carruthers (H)

School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia.

John Amerena (J)

Department of Cardiology, Barwon Health, Geelong, Vic, Australia.

Jennifer C Cooke (JC)

Department of Cardiology, Eastern Health, Melbourne, Vic, Australia; School of Medicine, Monash University, Melbourne, Vic, Australia.

Gautam Vaddadi (G)

Department of Cardiology, Northern Health, Melbourne, Vic, Australia.

Voltaire Nadurata (V)

Department of Cardiology, Bendigo Health, Bendigo,Vic, Australia.

Christopher M Reid (CM)

School of Public Health, Curtin University, Perth, WA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH